Novel Combination Oncolytic Adenoviral Gene Therapy Armed with Dm-dNK and CD40L for Breast Cancer.

CONCLUSION: Our data suggest enhanced, selective tumor cell killing using combined gene therapy with conditionally replicating adenovirus containing Dm-dNK suicide gene and exogenous CD40 ligation (CD40L-CD40).
PMID: 30848201 [PubMed - as supplied by publisher]

Source: Current Gene Therapy - March 5, 2019 Category: Genetics & Stem Cells Authors: Wang Q, Yang M, Zhang Y, Zhong L, Zheng X Tags: Curr Gene Ther Source Type: research